Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 5378: Lower Costs, More Transparency Act, S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 S.1375/H.R.830 - HELP Copays Act. Issues related to commercial delinking of PBMs in H.R. 6283/S.1542 Support for H.Res.709 - Supporting the designation of September 2023 as "National Cholesterol Education Month", and September 30, 2023, as LDL-C Awareness Day. Access and reimbursement for Part B and Part D drugs. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. H.R.5391, S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act H.R. 5378: Lower Costs More Transparency Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 Issues related to Part D delinking of PBMs in H.R.2880 - Protecting Patients Against PBM Abuses Act, and S.1967 - PBM Act
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
ALEX WHALEN LAWREN D GEER JOHN MCMANUS LAWREN D GEER ALEX WHALEN JOHN MCMANUS